Changchun BCHT Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Changchun BCHT Biotechnology has a total shareholder equity of CN¥4.2B and total debt of CN¥62.6M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥5.3B and CN¥1.1B respectively. Changchun BCHT Biotechnology's EBIT is CN¥450.1M making its interest coverage ratio -96.5. It has cash and short-term investments of CN¥277.9M.
Key information
1.5%
Debt to equity ratio
CN¥62.58m
Debt
| Interest coverage ratio | -96.5x |
| Cash | CN¥277.89m |
| Equity | CN¥4.20b |
| Total liabilities | CN¥1.11b |
| Total assets | CN¥5.31b |
Recent financial health updates
Recent updates
Market Might Still Lack Some Conviction On Changchun BCHT Biotechnology Co. (SHSE:688276) Even After 36% Share Price Boost
Oct 07
Analysts Just Slashed Their Changchun BCHT Biotechnology Co. (SHSE:688276) EPS Numbers
Aug 22Changchun BCHT Biotechnology Co. (SHSE:688276) Doing What It Can To Lift Shares
Jul 28Is Changchun BCHT Biotechnology (SHSE:688276) Using Too Much Debt?
Jun 19Changchun BCHT Biotechnology Co. (SHSE:688276) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
Apr 16We Think That There Are Issues Underlying Changchun BCHT Biotechnology's (SHSE:688276) Earnings
Mar 30Financial Position Analysis
Short Term Liabilities: 688276's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688276's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥47.1M).
Debt to Equity History and Analysis
Debt Level: 688276 has more cash than its total debt.
Reducing Debt: 688276's debt to equity ratio has reduced from 18.6% to 1.5% over the past 5 years.
Debt Coverage: 688276's debt is well covered by operating cash flow (582.5%).
Interest Coverage: 688276 earns more interest than it pays, so coverage of interest payments is not a concern.